This page has been archived on the Web

Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please contact us to request a format other than those available.

Health product recall

Propofol II (2013-11-25)

Starting date:
November 25, 2013
Posting date:
December 9, 2013
Type of communication:
Drug Recall
Subcategory:
Drugs
Hazard classification:
Type I
Source of recall:
Health Canada
Issue:
Product Safety
Audience:
General Public, Healthcare Professionals, Hospitals
Identification number:
RA-37037

Recalled Products

Propofol II

Reason

A visible particule was observed during the inspection of retained samples from the injectable emulsion Propofol-II (batch 29609DJ).

Depth of distribution

Wholesalers, hospitals and pharmacies.

Affected products

Propofol II

DIN, NPN, DIN-HIM
DIN 02376865
Dosage form

Emulsion

Strength

10 mg/mL

Lot or serial number

29609DJ

Companies
Recalling Firm
Hospira Healthcare Corporation
1111 Dr. Frederik Philips Blvd.,
Saint-Laurent
H4M 2X6
Quebec
CANADA
Marketing Authorization Holder
Hospira Healthcare Corporation
1111 Dr. Frederik Philips Blvd.,
Saint-Laurent
H4M 2X6
Quebec
CANADA